Nobel Prize in Medicine-2025

Nobel Research Award-2024

American Academy of Dermatology, USA

Dr. Howard Maibach is a dermatologist with expertise in treating contact dermatitis (a rash caused by touching an irritating substance) and occupational dermatitis (a rash resulting from workplace exposure to an irritating substance). His specialties include allergic skin disorders and skin conditions caused by exposure to toxic substances. He also has an interest in dermatopharmacology, the study of medications for skin disorders. Maibach earned his medical degree from Tulane University School of Medicine. He completed a residency as well as a fellowship in dermatology at the Hospital of the University of Pennsylvania. Maibach has served on the editorial boards of more than 30 scientific journals. He is a member of 19 professional societies, including the American Academy of Dermatology, San Francisco Dermatological Society and International Commission on Occupational Health.

AstraZeneca, USA

University of Jeddah, Saudi Arabia

Dr. Mohammed Nabih Baeshen is a distinguished Professor of Microbial Biotechnology in the Department of Environmental Sciences at the College of Science, University of Jeddah. He earned his Ph.D. in Microbiology in 2009, M.Sc. in Parasitology in 2000, and B.Sc. in Zoology in 1992, all from King Abdulaziz University. Dr. Baeshen's academic journey includes serving as an Assistant Professor in various faculties at King Abdulaziz University from 2009 to 2013 and the University of Jeddah from 2013 to 2017. He later became an Associate Professor at the University of Jeddah in 2017 and was promoted to Professor in 2022. His administrative roles include Vice Dean of the College of Health Sciences (2012-2014), Vice Dean of the Faculty of Science (2017-2018), Chairman of the Biochemistry Department (2018-2020), and Chairman of the Physics Department (2019-2020) at the University of Jeddah. Dr. Baeshen's research interests focus on environmental sciences, environmental genomics (OMICS), and drug discovery from natural resources.

University of Algarve, Portugal

Pedro Fonte is an Assistant Professor at the Faculty of Sciences and Technology, University of Algarve, Portugal. He is an Integrated Member of the Center for Marine Sciences (CCMAR) at the University of Algarve and a Collaborative Researcher at the Institute for Bioengineering and Biosciences (iBB) at Instituto Superior Técnico, University of Lisbon. He has expertise on developing cutting-edge nanocarriers for drug delivery. His research is dedicated to pioneering targeted and controlled drug delivery systems that effectively cross biological barriers, enhancing treatment precision and efficacy. He is also a specialist in the lyophilization and solid-state characterization of pharmaceuticals and biopharmaceuticals, ensuring the stability and bioactivity of drugs. Moreover, his expertise extends to the structural characterization of therapeutic proteins, vital for advancing biopharmaceutical innovations. Currently, his groundbreaking work is primarily focused on revolutionary applications in cancer treatment and wound healing. Pedro Fonte has successfully coordinated several funded scientific projects, establishing valuable collaborations with researchers and academics worldwide. His publication record includes over 50 papers in high-impact peer-reviewed journals, 10 book chapters, and 1 edited book. His contributions to the scientific community and society have garnered him many awards and distinctions, including recognition as one of the Top 2% Scientists by Stanford University

Insitro,USA

Philip Tagari is insitro’s chief scientific officer, leading a team of multidisciplinary scientists and engineers who are redefining disease biology and implementing novel approaches to dramatically speed the delivery of meaningful therapeutics to patients with grievous disease. With more than 30 years of research and preclinical development experience, he brings expertise across neurobiology, metabolic disease, hematology/oncology, immunology and inflammation, cell and molecular biology, antibody discovery and biologics engineering, medicinal, peptide and oligonucleotide chemistry, analytical chemistry and biochemistry, structural biology, pharmacokinetics, safety pharmacology, laboratory automation and information technologies. Prior to insitro, Philip spent a decade as vice president of research (therapeutic discovery) at Amgen Inc. During that time, his global teams advanced over 30 innovative molecules into clinical development and commercialization including Lumukras® (first-in-class KRASG12C inhibitor); Tarlatamab (DLL3 BiTE®); AMG133 (anti-obesity bispecific) and Efavaleukin alfa (AMG 592) a novel IL-2 mutein Fc fusion. He is a director of CQDM (Consortium Quebecois sur la Decouverte du Medicament; Quebec Consortium for Drug Discovery) and SAB member for BenchSci (biology machine learning), NutcrackeRx (mRNA therapeutics) ad Amberstone Biosciences (novel biologics). Prior to joining Amgen in 1998, Philip was a research fellow at Merck Frosst (Canada) Inc, where he contributed to the discovery of Singulair® and Vioxx®, and performed basic research at McGill and Oxford Universities and the UK Medical Research Council.

University of Regensburg, Germany

University of Trieste,Italy

Gazi University, Turkey

Prof. Dr. Esra Küpeli Akkol is a Professor of Pharmacognosy at the Faculty of Pharmacy, Gazi University, Turkey. She received her B.Sc. in Pharmacy and Ph.D. in Pharmacognosy from Gazi University. Her academic career is distinguished by extensive experience in natural product research, drug discovery, and pharmacological evaluation of medicinal plants. She has made significant contributions to scientific publishing through her service on editorial boards and as a peer reviewer for numerous international journals, including Journal of Ethnopharmacology, Molecules, Current Neuropharmacology, Journal of Pharmaceutical Sciences, and Evidence-Based Complementary and Alternative Medicine. Her editorial expertise covers manuscript evaluation, reviewer coordination, and decision-making across multidisciplinary fields related to pharmacognosy and natural products. Prof. Akkol has supervised 58 funded research projects and 15 graduate theses, and has authored more than 300 SCI-indexed publications, along with national journal articles and international book chapters. She is an active member of the Society for Medicinal Plant and Natural Product Research (GA) and the Phytochemical Society of Europe (PSE). Her scientific achievements have been recognized by several prestigious awards, including TÜBİTAK scholarships, the Gazi University Honor Award, the Scientific Encouragement Award, and the Science Award from the Pharmacy Academy of the Association of Turkish Pharmacists. Her research integrates pharmacognosy, phytochemistry, and pharmacology, with a particular focus on bioassay-guided isolation of natural products, wound healing, anti-inflammatory and antinociceptive activities, neuropharmacology, gynecological and metabolic disorders, and anticancer drug discovery.

KLES College of Pharmacy India

Dr. Pramod J. Hurkadale, Professor, Department of Pharmacognosy, KLES College of Pharmacy, Belagavi, Karnataka, India has completed his B. Pharm degree from Kuvempu University, Shivamogga obtained his M. Pharm degree with distinction from Rajiv Gandhi University of Health Sciences. Bangalore. He has been awarded Ph.D. in Pharmaceutical Sciences from Rajiv Gandhi University of Health Sciences, Bengaluru under AICTE sponsored quality improvement program and also Diploma in Clinical Research from Catalyst Clinical Services Ltd, New Delhi. Dr. Pramod has put-up Twenty-Two years of teaching and research experience in UG, PG and guided 10 scholars for their Ph. D programs under KLE University. He has published and presented research papers in national and international journals/conferences and authored a book in Elsevier publishers, CBS publishers and book chapter in Studium Press, USA. He also been invited as speaker for international conferences at Malaysia, South Africa, Dubai, Brunei, Singapore, Thailand, Srilanka, Nepal, Egypt, Saudi Arabia, Bangladesh and Japan He has been awarded Best of the Batch Award from Zydus-Indon Cadila Health Care Ltd, Ahmedabad, Best Paper in International & National Conferences and Best Teacher Award. He is also the Member for various professional bodies APTI, ISP, SFE, KSPC etc. He has also worked as Secretary to organize several workshops/ conferences National and International which was sponsored by ICMR, AICTE, UGC, IPA, etc. and currently EC Member & Coordinator, Society of Pharmacognosy, India and Co-ordinator for society for Ethnopharmacology for Belagavi Chapter. His areas of research interest are, herbal formulations /excipients, biosurfactants, traditional medicines, ethnomedicinal plants and their screening for various pharmacological activities and jointly collaborated with National Institute of Traditional Medicine, ICMR, Belagavi on tissue culture studies of Medicinal Plants from Western Ghats region.

University Kebangsaan Malaysia, Malaysia

Marma Health Centre, India

A practicing physician in the field of healthcare in the state of Kerala in India for the last 37 years and very much interested in basic research. My interest is spread across the fever, inflammation and back pain. I am a writer. I already printed and published Ten books on these subjects. I wrote hundreds of articles in various magazines. I have published 15 articles on fever in various journals. After scientific studies, we have developed 8000 affirmative cross checking questions. It can explain all queries related to fever.

Dr. L. H. Hiranandani College of Pharmacy, India